Business Standard

Monday, December 23, 2024 | 12:25 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Setbacks to Serum Institute of India leave world short of Covid shots

The world's largest vaccine maker has been dogged by problems, from a ban on exports to a factory fire, that have hampered its ability to fill orders

The world’s largest vaccine maker, Serum was last year named a top supplier of Covid shots to Covax, the World Health Organization-backed initiative aimed at securing an equitable global rollout. (Photo: Bloomberg)
Premium

The world’s largest vaccine maker, Serum was last year named a top supplier of Covid shots to Covax, the World Health Organization-backed initiative aimed at securing an equitable global rollout. (Photo: Bloomberg)

Chris Kay & P R Sanjai | Bloomberg
Around the world, from Bangladesh to Nepal to Rwanda, vulnerable hotspots have been grappling with stalled Covid-19 vaccination programs as they run out of doses. Many of those shortages can be traced back to a single company: The Serum Institute of India.
 
The world’s largest vaccine maker, Serum was last year named a top supplier of Covid shots to Covax, the World Health Organization-backed initiative aimed at securing an equitable global rollout. But the Indian company has been dogged by setbacks, from a ban on exports to a factory fire, that have hampered its ability to fill orders.

Covax has

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in